Skip to content

Effects of decreasing serum trioxypurine on cognitive imparement after cerebral infarction: a prospective clinical study

Effects of decreasing serum trioxypurine on cognitive imparement after cerebral infarction: a prospective clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-15006984
Enrollment
Unknown
Registered
2015-08-28
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment after ischemic stroke

Interventions

Group of decreasing serum trioxypurine:Treatment of decreasing serum trioxypurine

Sponsors

Shenzhen People's Hospital (2nd Clinical Medical College of Jinan University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Being true of the diagnostic criteria of the World Health Organization for ischemic stroke; 2. aged from 30 to 75 years; 3. the onset time within 3 days; 4. patients or their families sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Excluded the patients with obvious cognitive disorders and others caused by infectious diseases, metabolic diseases, Parkinson's syndrome or other neurodegenerative diseases before suffer from cerebral infarction; 2. patients with coma or mental disorder; 3. patients with aphasia, visual hearing impairment; 4. the patients are participating in other clinical trials; 5. illiterate patients.

Design outcomes

Primary

MeasureTime frame
cognitive function assessment;Value of serum trioxypurine;

Countries

China

Contacts

Public ContactYitao He
heyitaovv@126.com+86 13590419894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026